knowledge -WSS

knowledge

author：fashion 2025-09-29 22:47:19 - browse：7

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

LONDON — A U.K. government agency on Tuesday said that it won’t recommend Eli Lilly’s Mounjaro — part of a new class of medications that help patients lose weight — for people with type 2 diabetes without additional evidence.

Mounjaro, also known as tirzepatide, has U.S. approval for type 2 diabetes and is expected to win the regulatory green light for obesity later this year. It is one of several medications, along with Wegovy and Ozempic from Novo Nordisk, that have shown dramatic weight loss results, creating a surge in demand and blockbuster sales expectations.

But in draft guidance, the U.K.’s National Institute for Health and Care Excellence, which assesses the cost-effectiveness of medications, said it had asked Lilly for more data “to address the uncertainties in the clinical evidence, when compared to all relevant alternative treatments.” NICE recommendations are used by the National Health Service to determine whether to provide certain medications.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： New oral drug delivery patch is modeled after octopus tentacles

explore

WSS

WHO recommends second malaria vaccine

David Sabatini, ex

With Roe v Wade overturned, abortion providers work to adapt

Scientists successfully use ultrasound imaging to map brain activity

Scientists successfully use ultrasound imaging to map brain activity

AI used to predict Covid

Wikipedia

knowledge

leisure time

What does generative AI mean for health care? We asked experts

Health insurers say they are turning to AI to cut costs, improve care

Drug repurposing or repositioning? The language matters

Do more moles mean more problems? Not so, says new study

Alkermes shareholders re

First Opinion Podcast: What happens when kids become caregivers?

The high cost of giving birth even with insurance

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

Continuity nursing helped my family in our darkest PICU moments

Report: NIH

hotspot

Study points to new risk in gene therapy death of Terry Horgan

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

Experts study whether long Covid risk adds up with each reinfection

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

Report: NIH

Dark money group runs ads on China biotech bill

hotspot

hotspot

explore

leisure time